Home Interviews Alligator Bioscience on the importance of prolonging life

Alligator Bioscience on the importance of prolonging life

Søren Bergenholt, vd Alligator Bioscience hos BioStock

Alligator Bioscience on the importance of prolonging life

2 April, 2024

What does time mean to a person who’s cancer might not be cured? Prolonged life can bring hope for alternative treatments, or simply allow more time with loved ones. Alligator Bioscience aim to help patients with pancreatic cancer, through activating the body’s own immune system. As the FDA has endorsed a phase III study with the company’s lead candidate, BioStock studio asked CEO Søren Bregenholt to expand on the next step and his personal engagement in helping cancerpatients.

Watch the interview with Søren Bregenholt, CEO of Alligator Bioscience, below.

YouTube video

IMPORTANT INFORMATION 

This material constitutes an introduction to the rights issue of units in Alligator (the ”Rights Issue”) and should be regarded as marketing material. The material is not and shall not be considered to constitute a prospectus in accordance with applicable laws and regulations. Invitation to shareholders and the public to subscribe for units in the Rights Issue takes place only through the prospectus that has been approved and registered by the Swedish Financial Supervisory Authority (the ”Prospectus”), and which has been published on www.alligatorbioscience.se/en/investors/preferential-rights-issue-q1-2024/. The Swedish Financial Supervisory Authority’s approval of the Prospectus shall not be construed as an approval of the new shares or warrants. In order for an investor to fully understand the potential risks and benefits associated with the decision to participate in the Rights Issue, any investment decision should only be made based on the information in the Prospectus. Investors are advised to read the full Prospectus. 

Artikelns innehåll är sponsrat av det aktuella bolaget som förekommer i texten. BioStock tillhandahåller inte investeringsrådgivning, förmedlar inga investeringsorder och tar inget ansvar för agerande och/eller eventuell förlust eller skada av något slag som grundar sig på användandet av innehåll som publicerats på BioStock.se. Varje investeringsbeslut fattas istället självständigt av den enskilde investeraren.

Prenumerera på BioStocks nyhetsbrev